Wedbush Says Arena (ARNA) News is Not New; Recommends Buying VIVUS (VVUS) on 'Any Sympathetic Weakness'
Tweet Send to a Friend
Wedbush has issued an intraday research note on VIVUS (Nasdaq: VVUS) following the FDA's briefing documents for the upcoming EMDAC ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
